These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7999264)

  • 1. DNA recombination induced by aflatoxin B1 activated by cytochrome P450 1A enzymes.
    Sengstag C; Würgler FE
    Mol Carcinog; 1994 Dec; 11(4):227-35. PubMed ID: 7999264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High promutagen activating capacity of yeast microsomes containing human cytochrome P-450 1A and human NADPH-cytochrome P-450 reductase.
    Sengstag C; Eugster HP; Würgler FE
    Carcinogenesis; 1994 May; 15(5):837-43. PubMed ID: 8200084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotoxicity of aflatoxin B1: evidence for a recombination-mediated mechanism in Saccharomyces cerevisiae.
    Sengstag C; Weibel B; Fasullo M
    Cancer Res; 1996 Dec; 56(23):5457-65. PubMed ID: 8968101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterocyclic aromatic amines efficiently induce mitotic recombination in metabolically competent Saccharomyces cerevisiae strains.
    Paladino G; Weibel B; Sengstag C
    Carcinogenesis; 1999 Nov; 20(11):2143-52. PubMed ID: 10545418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1.
    Shimada T; Hayes CL; Yamazaki H; Amin S; Hecht SS; Guengerich FP; Sutter TR
    Cancer Res; 1996 Jul; 56(13):2979-84. PubMed ID: 8674051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of aflatoxin B1 by mouse CYP2A enzymes and cytotoxicity in recombinant yeast cells.
    Pelkonen P; Lang MA; Wild CP; Negishi M; Juvonen RO
    Eur J Pharmacol; 1994 Nov; 292(1):67-73. PubMed ID: 7867691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apiaceous vegetable constituents inhibit human cytochrome P-450 1A2 (hCYP1A2) activity and hCYP1A2-mediated mutagenicity of aflatoxin B1.
    Peterson S; Lampe JW; Bammler TK; Gross-Steinmeyer K; Eaton DL
    Food Chem Toxicol; 2006 Sep; 44(9):1474-84. PubMed ID: 16762476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of promutagens catalyzed by Drosophila melanogaster CYP6A2 enzyme in Saccharomyces cerevisiae.
    Saner C; Weibel B; Wurgler FE; Sengstag C
    Environ Mol Mutagen; 1996; 27(1):46-58. PubMed ID: 8625948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of human microsomal epoxide hydrolase in Saccharomyces cerevisiae reveals a functional role in aflatoxin B1 detoxification.
    Kelly EJ; Erickson KE; Sengstag C; Eaton DL
    Toxicol Sci; 2002 Jan; 65(1):35-42. PubMed ID: 11752683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Escherichia coli MTC, a human NADPH P450 reductase competent mutagenicity tester strain for the expression of human cytochrome P450 isoforms 1A1, 1A2, 2A6, 3A4, or 3A5: catalytic activities and mutagenicity studies.
    Kranendonk M; Carreira F; Theisen P; Laires A; Fisher CW; Rueff J; Estabrook RW; Vermeulen NP
    Mutat Res; 1999 Apr; 441(1):73-83. PubMed ID: 10224324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of aflatoxin B1 by expression of human CYP1A2 polymorphisms in Saccharomyces cerevisiae.
    Fasullo M; Smith A; Egner P; Cera C
    Mutat Res Genet Toxicol Environ Mutagen; 2014 Feb; 761():18-26. PubMed ID: 24472830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic activation of polycyclic aromatic hydrocarbons and other procarcinogens by cytochromes P450 1A1 and P450 1B1 allelic variants and other human cytochromes P450 in Salmonella typhimurium NM2009.
    Shimada T; Oda Y; Gillam EM; Guengerich FP; Inoue K
    Drug Metab Dispos; 2001 Sep; 29(9):1176-82. PubMed ID: 11502724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic activation of heterocyclic amines and other procarcinogens in Salmonella typhimurium umu tester strains expressing human cytochrome P4501A1, 1A2, 1B1, 2C9, 2D6, 2E1, and 3A4 and human NADPH-P450 reductase and bacterial O-acetyltransferase.
    Oda Y; Aryal P; Terashita T; Gillam EM; Guengerich FP; Shimada T
    Mutat Res; 2001 May; 492(1-2):81-90. PubMed ID: 11377247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oltipraz-mediated changes in aflatoxin B(1) biotransformation in rat liver: implications for human chemointervention.
    Buetler TM; Bammler TK; Hayes JD; Eaton DL
    Cancer Res; 1996 May; 56(10):2306-13. PubMed ID: 8625305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specificity of rat liver cytochrome P-450 isozymes in the mutagenic activation of benzo[a]pyrene, aromatic amines and aflatoxin B1.
    Robertson IG; Zeiger E; Goldstein JA
    Carcinogenesis; 1983; 4(1):93-6. PubMed ID: 6295661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition by green tea catechins of metabolic activation of procarcinogens by human cytochrome P450.
    Muto S; Fujita K; Yamazaki Y; Kamataki T
    Mutat Res; 2001 Aug; 479(1-2):197-206. PubMed ID: 11470492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of ten strains of genetically engineered Salmonella typhimurium TA1538 each co-expressing a form of human cytochrome P450 with NADPH-cytochrome P450 reductase sensitive to various promutagens.
    Yamazaki Y; Fujita K; Nakayama K; Suzuki A; Nakamura K; Yamazaki H; Kamataki T
    Mutat Res; 2004 Aug; 562(1-2):151-62. PubMed ID: 15279838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of aflatoxin B1 with cytochrome P450 2A5 and its mutants: correlation with metabolic activation and toxicity.
    Pelkonen P; Lang MA; Negishi M; Wild CP; Juvonen RO
    Chem Res Toxicol; 1997 Jan; 10(1):85-90. PubMed ID: 9074807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of a novel host, high-red yeast that stably expresses hamster NADPH-cytochrome P450 oxidoreductase: usefulness for examination of the function of mammalian cytochrome P450.
    Ohgiya S; Goda T; Hoshino T; Kamataki T; Ishizaki K
    Arch Biochem Biophys; 1997 Jul; 343(2):215-24. PubMed ID: 9224733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative aflatoxin B(1) activation and cytotoxicity in human bronchial cells expressing cytochromes P450 1A2 and 3A4.
    Van Vleet TR; Macé K; Coulombe RA
    Cancer Res; 2002 Jan; 62(1):105-12. PubMed ID: 11782366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.